News
Gardiner Harris’s investigation of Johnson & Johnson explores the many ways corporate greed and weak regulations fail to ...
The Food and Drug Administration is reversing course on its requirement for all staffers to report to the office ...
Healthcare and medical technology company Johnson & Johnson (JNJ) has reported first-quarter financial results that beat Wall ...
Johnson & Johnson stock slipped Tuesday, even after the company reported first-quarter earnings that surpassed expectations ...
For medical-technology and pharmaceuticals manufacturing, “the most effective answer is not tariffs but tax policy,” Johnson ...
Health care giant Johnson ... drug Risperdal to the company’s role in the nation’s opioid crisis. But Harris doesn’t spare others from scrutiny or criticism with his book. Namely, he focuses on ...
The global pharmaceutical industry could generate about $1.2 trillion in sales in 2025, according to Statista, and projections call for 4.7% annual growth through 2029. The cancer treatment ...
At the American Urological Association (AUA) that starts later this week, J&J is scheduled to report that TAR-200 achieved a ...
A company that makes baby food for Target is recalling more than 25,000 packages of a product because it may contain elevated ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback